×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Dishman Pharmaceuticals
Dishman Pharmaceuticals
Ads
Buy Dishman Pharma; target of Rs 198: Karvy
Hold GlaxoSmithKline Pharma: Ambareesh Baliga
Buy CEAT, Dishman Pharmaceuticals: Angel Broking
Prefer L&T, BHEL to GMR Infra: Sukhani
Buy Exide Industries, says Sudarshan Sukhani
Buy Reliance Industries around Rs 750-755: Baliga
Dishman Pharma expects 25% growth in FY13
Buy Dishman Pharmaceuticals; target Rs 68: Angel Broking
Dishman Pharma eyes over 15% topline growth going forward
Dishman's Swiss subsidiary to get nod for high potency drug
Hold Dishman Pharma; target Rs 100: KRChoksey
Pharma firms want tax cuts, R&D sops boost
Buy Dishman Pharma; target of Rs 123: Angel Broking
Dishman Pharma Dec qtr PAT seen down 47% at Rs 17cr: Karvy
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio